Home › Clear-cell metastatic renal cell carcinoma › Ohio › Cleveland
Clear-cell metastatic renal cell carcinoma clinical trials in Cleveland, OH
4 studies for Clear-cell metastatic renal cell carcinoma are looking for participants at sites in and around Cleveland (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
RecruitingPhase 1
- NEO-811 Cleveland Site, Cleveland
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
RecruitingPhase 3
- Research Site, Cleveland
Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study
RecruitingPhase 2
- University Hospitals Seidman Cancer Center, Cleveland
- Cleveland Clinic, Cleveland
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
RecruitingPhase 3
- Case Western Reserve University, Cleveland
- UHHS-Chagrin Highlands Medical Center, Beachwood · 10 mi away
- UH Seidman Cancer Center at Lake Health Mentor Campus, Mentor · 22 mi away
Clear-cell metastatic renal cell carcinoma trials in other cities
- Baldwin Park, CA7 studies
- New York City, NY5 studies
- Dallas, TX5 studies
- Nashville, TN5 studies
- Rochester, MN4 studies
- Waukegan, IL4 studies
- St. Louis, MO4 studies
- Ann Arbor, MI3 studies
- San Francisco, CA3 studies
- Houston, TX3 studies
- San Diego, CA3 studies
- Omaha, NE3 studies
Other studies in Cleveland
- Non-Small Cell Lung Cancer43 studies
- Cancer (all types)36 studies
- Breast Cancer35 studies
- Prostate Cancer34 studies
- Heart Failure33 studies
- Ovarian Cancer30 studies
- Metastatic Cancer30 studies
- Lung Cancer26 studies
- Colorectal Cancer24 studies
- Cardiovascular Disease22 studies
- Endometrial Cancer20 studies
- Acute Myeloid Leukemia20 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.